Histosonics is a medical device company that is developing histotripsy, a non-invasive, image guided, robotically controlled tissue ablation technology that uses intense ultrasound to liquefy soft tissue without a residual heat effect. Histotripsy will have broad applicability in replacing traditional surgical methods in treating conditions such as benign prostatic hyperplasia (BPH), prostate cancer, solid tupors and deep vein thrombosis.